INAMED CORP
NT 10-Q, 1997-11-17
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Previous: ZERO CORP, 10-Q, 1997-11-17
Next: SALOMON INC, 424B3, 1997-11-17





                          United States
               SECURITIES AND EXCHANGE COMMISSION

                     Washington, D.C.  20549




                           FORM 12b-25

                   NOTIFICATION OF LATE FILING

                          (Check one):

[ ] Form 10-K   [ ] Form 20-F    [ ] Form 11-K   [X]Form 10-Q    [ ] Form N-SAR

For Period Ended: September 30, 1997

[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR

For the Transition Period Ended:

Read Attached Instruction Sheet Before Preparing Form.  Please
Print or Type.

Nothing in this form shall be construed to imply that the
Commission has verified any
information contained herein.

If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:
not applicable

Part I - Registrant Information

Full Name of Registrant

INAMED CORPORATION

Address of Principal Executive Office:

3800 Howard Hughes Parkway, Suite #900
Las Vegas, Nevada  89109







Part II - Rules 12b-25 (b) and (c)

If the subject report could not be filed without unreasonable
effort or expense and the registrant seeks relief pursuant to
Rule 12b-25(b), the following should be completed.  (Check box if
appropriate)

[X]       (a) The reasons described in reasonable detail in Part
              III of this form could not be eliminated without 
              unreasonable effort or expense;

[X]       (b) The subject annual report, semi-annual report, transition 
              report on Form 10-K, Form    20-F, 11-K or From N-SAR,
              or portion thereof will be filed on or before the fifteenth
              calendar day following the prescribed due date; or the
              subject quarterly report or transition report on Form 10-Q, 
              or portion thereof will be filed on or before the fifth 
              calendar day following the prescribed due date; and

[ ]       (c) The accountant's statement or other exhibit
              required by Rule 12b-25(c) has been attached if applicable

Part III - Narrative

State below in reasonable detail the reason why Form 10-K, 20-F,
11-K, 10-Q, N-SAR or the transition report or portion thereof
could not be filed within the prescribed time period.

As previously disclosed in press releases dated April 1, April
15, May 8 and May 15, 1997, the Company has unable to timely file
its audited annual report on Form 10-K for calendar/fiscal year
1996.  Because the audited Form 10-K has not yet been completed,
the Form 10-Q for the third quarter of 1997 could not be filed
within its prescribed time period without unreasonable effort or
expense.

Part IV - Other Information

(1) Name and telephone number of person to contact in regard to
this notification

Donald K. McGhan, Chairman of the Board and Chief Executive
Officer   INAMED Corporation  (702) 791-3388

(2) Have all other periodic reports required under section 13 or
15 (d) of the Securities Exchange Act of 1934 or section 30 of
the Investment Company Act of 1940 during the preceding 12 months
or for such shorter periods that the registrant was required to
file such report(s) been filed? If the answer is no, identify
report(s).
                              [X] Yes   [ ] NO


(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year
will be reflected by the earning statements to be included in the
subject report or portion thereof?
                              [ ] Yes   [X] NO

If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and if appropriate, state the
reasons why a reasonable estimate of the results cannot be made.






                       INAMED CORPORATION

has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.

Date:  November  14, 1997            By  /s/  Donald  K. McGhan
                                         Chairman of the Board and CEO



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission